We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Ansell is a medical instruments & supplies business based in Australia. Ansell shares (ANN) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Ansell has a trailing 12-month revenue of around $2.1 billion. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
| 52-week range | $21.11 - $42.7966 |
|---|---|
| 50-day moving average | $25.5552 |
| 200-day moving average | $28.8486 |
| Target price | $28.56 |
| PE ratio | 9.4548 |
| Dividend yield | $0.678 (4.4%) |
| Earnings per share (TTM) | $2.421 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$22.9
| 1 week (2022-06-22) | 6.56% |
|---|---|
| 1 month (2022-05-27) | -16.24% |
| 3 months (2022-03-29) | -9.74% |
| 6 months (2021-12-29) | -28.86% |
| 1 year (2021-06-29) | -47.19% |
|---|---|
| 2 years (2020-06-29) | -35.85% |
| 3 years (2019-06-28) | -14.71% |
| 5 years (2017-06-29) | -4.54% |
Valuing Ansell stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ansell's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ansell's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Ansell shares trade at around 9x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ansell's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $338.5 million (£0.0 million).
The EBITDA is a measure of a Ansell's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.1 billion |
|---|---|
| Operating margin TTM | 14.28% |
| Gross profit TTM | $810 million |
| Return on assets TTM | 7.22% |
| Return on equity TTM | 14.38% |
| Profit margin | 10.39% |
| Book value | 12.104 |
| Market capitalisation | $2.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 44.96% of net profits
Recently Ansell has paid out, on average, around 44.96% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.4% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Ansell shareholders could enjoy a 4.4% return on their shares, in the form of dividend payments. In Ansell's case, that would currently equate to about A$0.678 per share.
While Ansell's payout ratio might seem fairly standard, it's worth remembering that Ansell may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 21 February 2022 (the "ex-dividend date").
Ansell's shares were split on a 1:5 basis on 15 April 2002. So if you had owned 5 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Ansell shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Ansell shares which in turn could have impacted Ansell's share price.
Over the last 12 months, Ansell's shares have ranged in value from as little as $21.11 up to $42.7966. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Ansell's is 0.375. This would suggest that Ansell's shares are less volatile than average (for this exchange).
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia. P. D. Holdings Pty. Ltd. operates as a current subsidiary of Ansell Limited.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
Steps to owning and managing Endeavour Group shares.
